Man Loses 25 Pounds on New GLP-1 Pill Foundayo

A New Era in Weight Loss: Foundayo from Eli Lilly

Foundayo, a groundbreaking weight loss pill from Eli Lilly, has made history as the first oral GLP-1 medication that doesn’t require fasting. This development marks a significant shift in the treatment of weight loss and type 2 diabetes, offering patients a more convenient alternative to existing options.

In clinical trials, participants experienced an average weight loss of 8-25 pounds while taking the drug. One individual who took the pill for 18 months reported a 25-pound weight loss, attributing it to reduced appetite and improved digestion. The FDA recently approved Foundayo, making it the first no-fuss once-daily GLP-1 pill for weight loss.

The Convenience of a Daily Pill

For years, patients using GLP-1 drugs had to choose between weekly injections or daily pills that required specific conditions, such as taking them on an empty stomach. Foundayo, generically known as orforgipron, offers a new level of convenience, allowing users to integrate it into their daily routines at any time of day.

This innovation is a major win for Eli Lilly, potentially expanding its market to millions of patients seeking the simplicity of a daily pill. The ability to take the medication alongside other prescriptions makes it an attractive option for those with busy schedules.

Real-Life Experience with Foundayo

Adam Salberg, a 59-year-old from New Jersey, was one of the first to test Foundayo during an 18-month clinical trial conducted by Eli Lilly in 2024 and 2025. Salberg had struggled with weight management despite multiple attempts at dieting and exercise. He enrolled in the trial hoping for a different approach.

The convenience of a daily pill appealed to him, especially since he already took other oral medications. “I travel a lot for work,” he explained. “It was very simple to add it to my existing regimen.”

Initial Effects and Adjustments

During the first five days of the trial, Salberg didn’t notice any changes. However, on the fifth night, he experienced a significant shift. “We were having roast chicken, and I only ate a portion before feeling completely satisfied,” he recalled. “I hadn’t felt that way before.”

Salberg also noted that his digestion slowed down, making him feel fuller faster. This change was surprising given his long-standing eating habits.

How GLP-1 Drugs Work

GLP-1 drugs mimic a natural hormone called glucagon-like peptide 1, which helps regulate hunger. These drugs are more potent than the body’s own hormone, leading to prolonged feelings of fullness and improved blood sugar control.

Common side effects of the drug include:
* Nausea (in 29-34% of patients, depending on the dosage)
* Constipation (22-25%)
* Diarrhea (21-23%)
* Vomiting (13-24%)

Lifestyle Changes and Weight Loss

Throughout the trial, Salberg adopted healthier habits. He began exercising three times a week, combining cardio and strength training to prevent muscle loss. He also adjusted his diet, replacing red meat and saturated fats with lean proteins like grilled fish and roasted chicken, along with plenty of vegetables.

By the end of the trial, Salberg had lost 25 pounds and maintained most of the weight loss. “It absolutely helped with losing weight,” he said. Although his appetite returned after six weeks off the medication, he managed to keep most of the weight off through portion control and healthy habits.

Future Plans and Cost Considerations

Now that Foundayo is available on the market, Salberg plans to discuss the medication with his doctor. If covered by insurance, the pill could cost as little as $25 per month. Eli Lilly also offers the medication directly on its website, with cash pay prices ranging from $149 to $349 per month, depending on the dose.

Pos terkait